Table 5 Site of care for patients developed post-vaccine COVID-19 infection group B (N = 70)
From: Prevalence and characteristics of COVID-19 vaccine breakthrough infection in Upper Egypt
Care site of treatment | N = 70 |
|---|---|
Home isolation | 50 (71.4%) |
Home oxygen therapy | 1 (1.4%) |
Hospital admission | 12 (17.1%) |
Intensive care unit isolation | 7 (10%) |